Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 9—September 2024
Synopsis

Onward Virus Transmission after Measles Secondary Vaccination Failure

Isaac TranterComments to Author , Nicolas Smoll, Colleen L. Lau, Dusty-Lee Williams, Deborah Neucom, Donna Barnekow, and Amalie Dyda
Author affiliations: University of Queensland, Herston, Queensland, Australia (I. Trantner, N. Smoll, C.L. Lau, A. Dyda); Sunshine Coast Hospital and Health Service, Maroochydore, Queensland, Australia (N. Smoll, D.-L. Williams, D. Neucom, D. Barnekow)

Main Article

Figure 2

Study-specific effect size by total reported measles SVF cases identified during systemic review of cases of onward virus transmission after measles SVF, as of March 31, 2023. Reff, effective reproduction number; SVF, secondary vaccination failure.

Figure 2. Study-specific effect size by total reported measles SVF cases identified during systemic review of cases of onward virus transmission after measles SVF, as of March 31, 2023. Reff, effective reproduction number; SVF, secondary vaccination failure.

Main Article

Page created: July 30, 2024
Page updated: August 22, 2024
Page reviewed: August 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external